Skip to main content
JSW Dulux Limited logo

JSW Dulux Limited — Investor Relations & Filings

Ticker · JSWDULUX ISIN · INE133A01011 BSE.NS Manufacturing
Open in API
Filings indexed 2,253 across all filing types
Latest filing 2025-08-08 Call Transcript
Country IN India
Listing BSE.NS JSWDULUX

About JSW Dulux Limited

https://www.jswpaints.in/

JSW Dulux Limited specializes in the development, manufacture, and distribution of a comprehensive range of decorative and industrial coating solutions. The company’s portfolio includes interior and exterior emulsions, protective finishes, enamels, and specialized wood coatings designed for both residential and commercial applications. Utilizing advanced chemical formulations, the organization focuses on delivering high-performance products characterized by durability, color precision, and environmental sustainability. Key offerings feature low-VOC compositions, weather-resistant technologies, and anti-microbial properties. The company serves a broad market spectrum, providing technical coating systems for infrastructure projects alongside consumer-grade paints. Its operations emphasize innovation in surface protection and aesthetic enhancement through rigorous research and development.

Recent filings

Filing Released Lang Actions
Pls find attached the transcript of the earnings call held on 5th August 2025.
Call Transcript Classification · 100% confidence The document is a detailed transcript of a group investor call held on August 5, 2025, discussing the financial results for the quarter ended June 30, 2025. It includes management remarks, Q&A with investors, and detailed discussion of quarterly performance, business outlook, and management changes. The presence of a moderator, multiple management speakers, and a Q&A session are typical features of an earnings call transcript. The document explicitly states it is a "Group Investor Call Transcript" and references the quarterly financial results. Therefore, this document fits the category of a Call Transcript (CT).
2025-08-08 English
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, providing an update on pending litigation as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It references an appeal order received from the Tamil Nadu GST Department and encloses details of the litigation status as an annexure. The document is relatively short (4106 characters) and serves as an update or announcement rather than a full report. It does not contain comprehensive financial statements or detailed analysis but rather a regulatory disclosure about litigation status. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2025-08-07 English
Please find attached an update on earlier disclosure made on 1st January 2024.
Regulatory Filings Classification · 95% confidence The document is a letter from Akzo Nobel India Limited addressed to stock exchanges, providing an update on pending litigation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It references a previous disclosure and provides details of a recent appeal order related to GST litigation. The document is short (3754 characters) and primarily serves as an update announcement rather than a full report. It does not contain financial statements or detailed financial analysis. The content fits the category of a Regulatory Filing (RNS) as it is a compliance disclosure about litigation status, not a full audit report or annual/interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-08-07 English
Appointment
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the appointment of a Secretarial Auditor, approved at the 71st Annual General Meeting (AGM). It references the AGM and the approval of the appointment by shareholders, including mention of the Scrutinizer's Report. The document is short (2268 characters) and serves as an intimation or announcement of a corporate governance event rather than a detailed report or financial statement. It does not contain financial data or detailed audit results, nor is it a transcript or presentation. Therefore, it fits best as a Regulatory Filing (RNS) since it is an official announcement under SEBI regulations about a corporate governance matter without being a full report or detailed filing.
2025-08-05 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal intimation under SEBI Listing Regulations providing the detailed voting results of the Annual General Meeting held on 4th August 2025, along with the Scrutinizer’s Report. It lists resolution-wise poll and e-voting outcomes. This clearly matches the definition of Declaration of Voting Results (DVA).
2025-08-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter dated 5th August 2025 from Akzo Nobel India Limited addressed to stock exchanges, informing about the outcome of a group investor call held on the same day. It references regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, and states that the call discussed the financial results for the quarter ended 30th June 2025. It mentions that a presentation was already shared and that the transcript of the call will be shared later. The document does not contain the transcript itself but is an announcement about the call and its outcome. Given the content and context, this document fits the category of a Call Transcript announcement or outcome notice. However, since the transcript is not included but will be shared later, and the document is primarily an announcement of the call outcome, the best fitting category is Call Transcript (CT). The document length is short and does not contain actual financial data or the transcript text, but it is specifically about the call and its outcome, which aligns with CT rather than a general regulatory filing or investor presentation.
2025-08-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.